middle.news
Island Pharmaceuticals Secures FDA Pathway and $9M to Advance Galidesivir for Marburg Virus
10:14am on Monday 27th of April, 2026 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Secures FDA Pathway and $9M to Advance Galidesivir for Marburg Virus
10:14am on Monday 27th of April, 2026 AEST
Key Points
FDA validates Galidesivir’s Marburg model and two-stage development plan
CRADA signed with USAMRIID and Geneva Foundation to support pivotal studies
New US patent strengthens Galidesivir’s intellectual property in filoviridae viruses
$9 million placement boosts cash reserves ahead of clinical milestones
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE